Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Takeda
>
THE BRINTELLIX LAUNCH MEETING ...
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 4945205"]Let's look at Brintellix actual potential from the field… not what the ass clowns in the home office think it will do…..</p><p><br /></p><p>So, Brintellix will be a first-line option for elderly patients with depression…. Let's break this down…. Elderly = Medicare….. Medicare = Not covered… hmmm… sounds more promising than the Edarbi marketing team...</p><p><br /></p><p>The U.S. antidepressant market peaked at $12 billion in 2008, lost $2.6 billion due to expired patents during the following years and currently stands at $9.4 billion. Over the past five years, the market has been declining, on average, by (-4%) per year. Currently, generics control over 40% of the market in terms of revenue and over 85% of the market in terms of prescriptions.. Hey, we can go after the 15%!!!.. Branded pharmaceutical companies are increasingly pulling out the antidepressant market, despite widespread use of the medication, as patent expiry and new drug development failures make it unprofitable to remain in the market….. Hmmmm… Doesn't this sound like the EDARBI sales pitch? </p><p><br /></p><p>Brintellix as a second-line therapy in patients who fail a generic selective serotonin reuptake inhibitor (SSRI). - Let's break this down…. Every SSRI is GENERIC, Prozac, Paxil, Zoloft, Celexa, Lexapro, Wellbutrin… so, you would think.. OPPORTUNITY!!!!…. </p><p><br /></p><p>The major problem is that Lundbeck only has data that compares to placebo. Welcome to the world of drug discovery and development. To be successful, you need to clearly differentiate new compounds from existing therapies. Little differentiation means little likelihood of success. Which based on Takeda's track record of successful launches………..[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 4945205"]Let's look at Brintellix actual potential from the field… not what the ass clowns in the home office think it will do….. So, Brintellix will be a first-line option for elderly patients with depression…. Let's break this down…. Elderly = Medicare….. Medicare = Not covered… hmmm… sounds more promising than the Edarbi marketing team... The U.S. antidepressant market peaked at $12 billion in 2008, lost $2.6 billion due to expired patents during the following years and currently stands at $9.4 billion. Over the past five years, the market has been declining, on average, by (-4%) per year. Currently, generics control over 40% of the market in terms of revenue and over 85% of the market in terms of prescriptions.. Hey, we can go after the 15%!!!.. Branded pharmaceutical companies are increasingly pulling out the antidepressant market, despite widespread use of the medication, as patent expiry and new drug development failures make it unprofitable to remain in the market….. Hmmmm… Doesn't this sound like the EDARBI sales pitch? Brintellix as a second-line therapy in patients who fail a generic selective serotonin reuptake inhibitor (SSRI). - Let's break this down…. Every SSRI is GENERIC, Prozac, Paxil, Zoloft, Celexa, Lexapro, Wellbutrin… so, you would think.. OPPORTUNITY!!!!…. The major problem is that Lundbeck only has data that compares to placebo. Welcome to the world of drug discovery and development. To be successful, you need to clearly differentiate new compounds from existing therapies. Little differentiation means little likelihood of success. Which based on Takeda's track record of successful launches………..[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Takeda
>
THE BRINTELLIX LAUNCH MEETING ...
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Takeda
>
THE BRINTELLIX LAUNCH MEETING ...
>